- Filed
- Oct 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 29, 2025 | 321.87M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $201M |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $117M |
| Dividends Paid | Q3 2025 · Sep 30, 2025 | $1.32B |
| Dividends Paid | Q3 2025 · Sep 30, 2024 | $1.28B |
| Capex | Q3 2025 · Sep 30, 2025 | $1.43B |
| Capex | Q3 2025 · Sep 30, 2024 | $1.34B |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $755M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $1.9B |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $137M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $119M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $1.78B |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $3.38B |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $10.6B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $12.46B |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $6.85B |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $6.71B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $10.76B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $12.27B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $33.79B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $35.75B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$2.77 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.89 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $1.75 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $6.00 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$2.77 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.89 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $1.76 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $6.02 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $401M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $1.24B |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $400M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $1.22B |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $34M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $103M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $31M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $96M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$731M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$332M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $865M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $2.52B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $6.82B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $20.82B |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $7.3B |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $21.75B |
| Revenue | Q3 2025 · Sep 30, 2025 | $7.73B |
| Revenue | Q3 2025 · Sep 30, 2025 | $23.06B |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $8.6B |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $25.59B |